@online{FDA_CAR-T_adult,
	author = {U.S. Department of Health and Human Services},
	title = {FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma},
	year = 2017,
	url = {https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm581216.htm},  urldate = {2017-12-21}
}

@online{FDA_CAR-T_ALL,
	author = {U.S. Department of Health and Human Services},
	title = {FDA approval brings first gene therapy to the United States},
	year = 2017,
	url = {https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm574058.htm},
	urldate = {2017-12-21}
}

@online{FDA_CTLA4,
	author = {U.S. Department of Health and Human Services},
	title = {FDA approves Yervoy to reduce the risk of melanoma returning after surgery},
	year = 2015,
	url = {https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm469944.htm},
	urldate = {2017-12-21}
}

@online{FDA_PDL1_Bladder,
	author = {U.S. Department of Health and Human Services},
	title = {FDA approves new, targeted treatment for bladder cancer},
	year = 2016,
	url = {https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm501762.htm},
	urldate = {2017-12-21}
}

@online{FDA_PDL1_NSCLC,
	author = {U.S. Department of Health and Human Services},
	title = {Pembrolizumab (KEYTRUDA) Checkpoint Inhibitor},
	year = 2016,
	url = {https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm526430.htm},
	urldate = {2017-12-21}
}